Premium
ADVANCED GLYCATION END PRODUCTS IN RENAL FAILURE: AN OVERVIEW
Author(s) -
Noordzij M.J.,
Lefrandt J.D.,
Smit A.J.
Publication year - 2008
Publication title -
journal of renal care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.381
H-Index - 27
eISSN - 1755-6686
pISSN - 1755-6678
DOI - 10.1111/j.1755-6686.2008.00038.x
Subject(s) - glycation , medicine , advanced glycation end product , diabetes mellitus , chronic renal failure , oxidative stress , transplantation , renal transplant , autofluorescence , pentosidine , cardiology , endocrinology , physics , quantum mechanics , fluorescence
SUMMARY The article aims to present an overview of the existing knowledge on advanced glycation end products (AGE). They are moieties that bind to proteins, but also lipids and nuclear acids. AGE are formed during glycation and oxidative stress. Accumulation of AGE occurs especially in diabetes and chronic renal failure and plays a major pathogenetic role. The deleterious effects of AGE result from cross‐linking of proteins and activation of the receptor for advanced glycation end products. AGE accumulation can be noninvasively assessed by the skin autofluorescence reader. In diabetics, the skin autofluorescence predicts cardiac mortality and the occurrence of macro‐ and microvascular complications. In patients on haemodialysis, skin autofluorescence is highly elevated and predicts mortality. After renal transplantation AGE accumulation is lower than during haemodialysis, but still remains elevated and is a strong risk factor for chronic renal transplant dysfunction. Some of the potential methods to intervene with AGE accumulation are discussed in this article.